ACRS ACLARIS THERAPEUTICS INC
2026Q1 · CUSIP 00461U105 · Sector: Healthcare & Biotech
Neutral · No signal
Holders
135
Δ holders QoQ
+13
Breadth percentile
Top 23%
Whale holders
77
Δ whales
+6
Inst. holding value
$406M
New positions
33
Closed positions
20
Price momentum (1Q)
+35.0%
Put / Call
2/3
Breadth history (34 quarters)
Past Lit Events & Aftermath 4 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2023Q1 | Top 8% | -13.8% | -90.3% |
| 2022Q3 | Top 10% | -26.9% | -54.5% |
| 2021Q2 | Top 6% | +9.1% | -13.1% |
| 2018Q4 | Top 18% | -23.5% | -86.5% |
Options Sentiment
Put holders
2
QoQ: +2
Call holders
3
QoQ: +1
See methodology →
Fundamentals
PE (TTM)
—
EPS (TTM)
$-0.56
EPS YoY
—
Revenue (TTM)
$0.0B
Revenue YoY
-52.9%
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
As of 2026-03-31 · SEC filings (XBRL)